Skip to main content

Transcranial Direct Current Stimulation Beneficial in Alzheimer Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 7, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 7, 2023 -- For patients with Alzheimer disease (AD), active transcranial direct current stimulation (tDCS) may improve cognitive function, according to a study published online Dec. 5 in General Psychiatry.

Xingxing Li, from the Ningbo Kangning Hospital & Affiliated Mental Health Centre at Ningbo University in China, and colleagues examined the role of tDCS in improving cognition among patients with AD. One hundred twenty-four patients were randomly assigned to active tDCS or sham tDCS (63 and 61 patients, respectively), applied at the dorsolateral prefrontal cortex for 30 treatment sessions across six weeks.

The researchers found that multiple courses of tDCS improved the cognitive functions of patients with AD, especially word recall, recall of test instructions, and word recognition in the memory domain. Following active treatment, there was enhancement in the damaged motor-evoked potential (MEP) level. Negative correlations were seen for improvements in the Alzheimer's Disease Assessment Scale-Cognitive total and subitem (word recall and word recognition) scores with the enhancement of MEP in the active tDCS group.

"The results of this study strongly indicate that tDCS treatment is a significant and promising intervention for improving cognitive function in AD," the authors write. "Further research is needed to elucidate the relationship between plasticity and cognition."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181

MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...

Lower Cognitive Function in Adolescence Linked to Stroke Risk

FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.